Search Result "cMET-Inhibitors"
The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1284-1292
Author(s): Francesco Passiglia,Nele Van Der Steen,Luis Raez,Patrick Pauwels,Ignacio Gil-Bazo,Edgardo Santos,Daniele Santini,Giovanni Tesoriere,Antonio Russo,Giuseppe Bronte,Karen Zwaenepoel,Federico Cappuzzo,Christian Rolfo
Clinical Experience with Antiangiogenic Therapy in Leukemia
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 9 Year: 2011 Page: 1053-1068
Author(s): J. Wellbrock, W. Fiedler
Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 8 Year: 2009 Page: 931-937
Author(s): J. Kao, A. T. Sikora, S. Fu
Medical Systemic Therapies for Hepatocellular Carcinoma: Clinical Perspectives and Safety Profile
Journal: Current Drug Safety
Volume: 10 Issue: 3 Year: 2015 Page: 202-207
Author(s): Antonio Facciorusso,Matteo Antonino,Valentina Del Prete,Annabianca Amoruso,Viviana Neve,Michele Barone
Cell Surface Markers and their Targeted Drugs in Breast Cancer
Journal: Current Protein & Peptide Science
Volume: 23 Issue: 5 Year: 2022 Page: 335-346
Author(s):
Clustering and Sampling of the c-Met Conformational Space: A Computational Drug Discovery Study
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 22 Issue: 9 Year: 2019 Page: 635-648
Author(s): Korosh Mashayekh,Shahrzad Sharifi,Tahereh Damghani,Maryam Elyasi,Mohammad S. Avestan,Somayeh Pirhadi
HGF and HGF Agonists, Expression in Wound and Potential Role in the Management of Wound Healing
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 2 Year: 2011 Page: 152-155
Author(s): Kevin Conway
Editorial [Hot topic: Hepatocyte Growth Factor and cMET, New Development in Cancer Therapies (Guest Editors: T.A. Martin and W.G. Jiang)]
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 1-1
Author(s): T. A. Martin, W. G. Jiang
SHR6390 Combined with Cabozantinib Inhibits Tumor Progression in theHepatocellular Carcinoma Mouse Model
Journal: Current Gene Therapy
Volume: 24 Issue: 5 Year: 2024 Page: 453-464
Author(s):
Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 4 Year: 2013 Page: 595-602
Author(s): Deniz A. Ucar, Andrew T. Magis, Di-Hua He, Nicholas J. Lawrence, Said M. Sebti, Elena Kurenova, Maria Zajac-Kaye, Jianliang Zhang, Steven N. Hochwald